A detailed history of Provident CO Of The Employees Of The Hebrew University LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Provident CO Of The Employees Of The Hebrew University LTD holds 12,965 shares of MRNA stock, worth $671,716. This represents 1.83% of its overall portfolio holdings.

Number of Shares
12,965
Previous 12,943 0.17%
Holding current value
$671,716
Previous $1.38 Billion 11.57%
% of portfolio
1.83%
Previous 1.46%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$101.21 - $166.61 $2,226 - $3,665
22 Added 0.17%
12,965 $1.54 Billion
Q1 2024

May 08, 2024

BUY
$85.37 - $115.44 $1.1 Million - $1.49 Million
12,943 New
12,943 $1.38 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $20.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Provident CO Of The Employees Of The Hebrew University LTD Portfolio

Follow Provident CO Of The Employees Of The Hebrew University LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Provident CO Of The Employees Of The Hebrew University LTD, based on Form 13F filings with the SEC.

News

Stay updated on Provident CO Of The Employees Of The Hebrew University LTD with notifications on news.